ATE184199T1 - Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen - Google Patents

Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen

Info

Publication number
ATE184199T1
ATE184199T1 AT94900578T AT94900578T ATE184199T1 AT E184199 T1 ATE184199 T1 AT E184199T1 AT 94900578 T AT94900578 T AT 94900578T AT 94900578 T AT94900578 T AT 94900578T AT E184199 T1 ATE184199 T1 AT E184199T1
Authority
AT
Austria
Prior art keywords
factor xiii
locally applied
prevent bleeding
applied factor
sites
Prior art date
Application number
AT94900578T
Other languages
English (en)
Inventor
Marc R Mayberg
Martin William Edwards
Original Assignee
Zymogenetics Inc
Marc R Mayberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc, Marc R Mayberg filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE184199T1 publication Critical patent/ATE184199T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT94900578T 1992-11-12 1993-11-09 Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen ATE184199T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97502692A 1992-11-12 1992-11-12

Publications (1)

Publication Number Publication Date
ATE184199T1 true ATE184199T1 (de) 1999-09-15

Family

ID=25522630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900578T ATE184199T1 (de) 1992-11-12 1993-11-09 Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen

Country Status (9)

Country Link
EP (1) EP0669834B1 (de)
JP (1) JP2004231664A (de)
AT (1) ATE184199T1 (de)
CA (1) CA2149209C (de)
DE (1) DE69326349T2 (de)
DK (1) DK0669834T3 (de)
ES (1) ES2139729T3 (de)
GR (1) GR3031890T3 (de)
WO (1) WO1994011022A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07328108A (ja) * 1994-06-10 1995-12-19 Ajinomoto Co Inc 生体組織接着剤及び血液凝固剤
EP1387691B1 (de) * 2001-02-21 2006-08-16 ZymoGenetics, Inc. Blutgerinnungsfaktor xiii zur behandlung von plättchenfunktionsstörungen
WO2005115442A1 (en) * 2004-05-25 2005-12-08 Novo Nordisk Health Care Ag Use of coagulation factor xiii for treatment of post surgical bleedings
WO2006021584A2 (en) 2004-08-27 2006-03-02 Novo Nordisk Health Care Ag Purification of factor xiii polypeptides from biological materials
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
DK1809342T3 (en) 2004-10-20 2015-08-17 Ethicon Inc absorbable hemostat

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
WO1989001512A1 (en) * 1987-08-17 1989-02-23 The Liposome Company, Inc. A sponge enzyme having transglutaminase-like activity
JPH01216939A (ja) * 1988-02-24 1989-08-30 Hoechst Japan Kk 末熟児頭蓋内出血阻止剤
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
DE69326349D1 (de) 1999-10-14
DK0669834T3 (da) 2000-04-17
WO1994011022A1 (en) 1994-05-26
GR3031890T3 (en) 2000-02-29
EP0669834B1 (de) 1999-09-08
JP2004231664A (ja) 2004-08-19
DE69326349T2 (de) 2000-03-02
JPH08505129A (ja) 1996-06-04
EP0669834A1 (de) 1995-09-06
CA2149209A1 (en) 1994-05-26
JP3884064B2 (ja) 2007-02-21
ES2139729T3 (es) 2000-02-16
CA2149209C (en) 2000-08-01

Similar Documents

Publication Publication Date Title
ATE217754T1 (de) Verwendung von aerogelen in der landwirtschaft
DE69625516D1 (de) Verwendung von il-10 zur wundheilung mit verminderter narbenbildung
DE68916512D1 (de) Zusammensetzung zur Verminderung von postoperativen Adhäsionen und ihre Verwendung.
PT991619E (pt) Inibidores da adesao celular mediada pela alfa4beta1
DE69634951D1 (de) Topische verwendung von betulinsäure zur behandlung bösartiger melanome
DE69711078T2 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
ATE184199T1 (de) Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
ATE275964T1 (de) Verwendung von betalycan zur verminderung der narbenbildung
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
BR0109896A (pt) Composição tópica em gel, curativo de feridas, seu método e uso
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
ATE238795T1 (de) Verwendung von aminothiazolen zur wund- und hautbehandlung
YU42401A (sh) Supstituisani heterociklični acil-tripeptidi korisni kao modulatori receptora trombina
DE60119285D1 (de) Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall
ATE320284T1 (de) Verwendung von mindestens einem derivat der 10- hydroxy-2-decenoicsäure in einer zusammensetzung zur förderung der abschuppung der haut
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
ES2188754T3 (es) Componente b como cicatrizante.
DE69912778D1 (de) Verwendung von wundverbänden zur behandlung von akuten wunden
UA36309A (uk) Спосіб лікування виразкової хвороби, ускладненої перфорацією або кровотечею, у людей похилого віку
ATE94759T1 (de) Verwendung von dextransulfat, gegebenenfalls in kombination mit anti-androgenen mitteln zur behandlung des humanen protatakarzinoms.
UA36531A (uk) Спосіб вибору тактики лікування гострої непрохідності тонкої кишки злукового походження
UA32281A (uk) Засіб "регенерин" для зовнішнього лікування гнійних ран і трофічних виразок

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner